Sangam: A Confluence of Knowledge Streams

The Role of Cyclooxygenase (COX)-2 in the Canine Proximal Gastrointestinal Tract

Show simple item record

dc.contributor Anthony Blikslager, Committee Member
dc.creator Wooten, Jenna Gray
dc.date 2010-04-02T18:29:45Z
dc.date 2010-04-02T18:29:45Z
dc.date 2008-12-05
dc.date.accessioned 2023-02-28T17:09:45Z
dc.date.available 2023-02-28T17:09:45Z
dc.identifier etd-11072008-104245
dc.identifier http://www.lib.ncsu.edu/resolver/1840.16/3400
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/265878
dc.description ABSTRACT WOOTEN, JENNA GRAY. The Role of Cyclooxygenase (COX)-2 in the Canine Proximal Gastrointestinal Tract (Under the direction of Drs. Anthony Blikslager and Duncan Lascelles) In veterinary medicine, NSAIDs are the most commonly prescribed analgesic and anti-inflammatory medications; unfortunately, they are also commonly associated with ulceration and perforation in dogs. Recent studies have indicated that the role of COX-2 appears to be more complicated than originally thought and its inhibition may lead to corresponding benefits or risks. Therefore, we investigated NSAIDs with differing degrees of selectivity and examined the role of COX-2 in the pylorus and duodenum. Each dog received carprofen (4.4 mg/kg, q 24 h), deracoxib (2 mg/kg, q 24 h), aspirin (10 mg/kg, q 12 h), and placebo (1 dog treat, q 24 h) orally for 3 days (4-week interval between treatments). Prostanoid synthesis was greater in pyloric mucosa than it was in duodenal mucosa. Nonselective NSAIDs significantly decreased prostanoid concentrations in these mucosae, compared with the effects of deracoxib. Following the same model dogs received deracoxib (2mg/kg q24h PO), firocoxib (5mg/kg q24h PO), meloxicam (Day 1=0.2mg/kg q24h PO, Day 2-3=0.1mg/kg q24h PO), or placebo (1 dog treat, q 24 h). There were no significant effects of varying COX-2 selectivity on gastric and duodenal tissue prostanoid concentrations, and no significant relationship between the degree of selectivity and gross or histological appearance of the mucosa, suggesting that there are no differences among the preferential and selective COX-2 inhibitors with regard to adverse effects on the upper GI tract. Twenty-seven clinically normal dogs were evaluated to determine if gastrointestinal lesions were present, and to determine if COX-1 and COX-2 expression were different in lesioned tissue compared to normal tissue. Findings show the gross appearance of a dog’s stomach will likely not provide definitive evidence of whether or not disease is present. From our results, COX-2 appears to be upregulated at the sites of inflammation and erosion and so in these situations, non-selective NSAIDs and COX-2 inhibitors could both be problematic, if this elevated COX-2 is actually playing a protective role. It is still not known if there is any difference between the selective COX-2 inhibitors and the non-selective NSAIDs in their ability to inhibit this upregulated COX-2 that is functioning in a protective role.
dc.rights I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dis sertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.
dc.subject cyclooxygenase
dc.subject gastrointestinal
dc.subject canine
dc.subject prostaglandins
dc.subject NSAIDs
dc.title The Role of Cyclooxygenase (COX)-2 in the Canine Proximal Gastrointestinal Tract


Files in this item

Files Size Format View
etd.pdf 539.9Kb application/pdf View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse